Literature DB >> 17182567

FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues.

Jee H Lee1, Seung G Kang, Chang H Kim.   

Abstract

Forkhead box P3 (FoxP3)-positive T cells are a specialized T cell subset for immune regulation and tolerance. We investigated the trafficking receptor switches of FoxP3(+) T cells in thymus and secondary lymphoid tissues and the functional consequences of these switches in migration. We found that FoxP3(+) T cells undergo two discrete developmental switches in trafficking receptors to migrate from primary to secondary and then to nonlymphoid tissues in a manner similar to conventional CD4(+) T cells as well as unique to the FoxP3(+) cell lineage. In the thymus, precursors of FoxP3(+) cells undergo the first trafficking receptor switch (CCR8/CCR9-->CXCR4-->CCR7), generating mostly homogeneous CD62L(+)CCR7(+)CXCR4(low)FoxP3(+) T cells. CXCR4 expression is regained in FoxP3(+) thymic emigrants in the periphery. Consistent with this switch, recent FoxP3(+) thymic emigrants migrate exclusively to secondary lymphoid tissues but poorly to nonlymphoid tissues. The FoxP3(+) thymic emigrants undergo the second switch in trafficking receptors for migration to nonlymphoid tissues upon Ag priming. This second switch involves down-regulation of CCR7 and CXCR4 but up-regulation of a number of memory/effector type homing receptors, resulting in generation of heterogeneous FoxP3(+) T cell subsets expressing various combinations of trafficking receptors including CCR2, CCR4, CCR6, CCR8, and CCR9. A notable difference between the FoxP3(+) and FoxP3(-) T cell populations is that FoxP3(+) T cells undergo the second homing receptor switch at a highly accelerated rate compared with FoxP3(-) T cells, generating FoxP3(+) T cells with unconventionally efficient migratory capacity to major nonlymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182567     DOI: 10.4049/jimmunol.178.1.301

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Cutting Edge: Dynamic Expression of Id3 Defines the Stepwise Differentiation of Tissue-Resident Regulatory T Cells.

Authors:  Jenna M Sullivan; Barbara Höllbacher; Daniel J Campbell
Journal:  J Immunol       Date:  2018-12-05       Impact factor: 5.422

Review 2.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

3.  High and low vitamin A therapies induce distinct FoxP3+ T-cell subsets and effectively control intestinal inflammation.

Authors:  Seung G Kang; Chuanwu Wang; Satoshi Matsumoto; Chang H Kim
Journal:  Gastroenterology       Date:  2009-07-24       Impact factor: 22.682

Review 4.  T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?

Authors:  Om Parkash; Sonali Agrawal; M Madhan Kumar
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

Review 5.  Immune Cell Trafficking to the Liver.

Authors:  Sulemon Chaudhry; Jean Emond; Adam Griesemer
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 6.  Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response.

Authors:  Thorsten R Mempel; Francesco Marangoni
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

Review 7.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

8.  BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.

Authors:  Barbara H Chaiyachati; Anant Jani; Yisong Wan; Haichang Huang; Richard Flavell; Tian Chi
Journal:  EMBO J       Date:  2013-01-15       Impact factor: 11.598

Review 9.  Regulatory T Cells for More Targeted Immunosuppressive Therapies.

Authors:  Hazim Allos; Basmah S Al Dulaijan; John Choi; Jamil Azzi
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

10.  Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis.

Authors:  Sebastian Doerck; Kerstin Göbel; Gesa Weise; Tilman Schneider-Hohendorf; Michael Reinhardt; Peter Hauff; Nicholas Schwab; Ralf Linker; Mathias Mäurer; Sven G Meuth; Heinz Wiendl
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.